Frontlight ResearchEarly access
Taking people in United StatesNo phase
Collects health data and samples from people with plasma cell disorders
Gathers health information and samples from adults with plasma cell disorders for future research.
Key facts
- Who runs it
- Indiana University
- Where
- Indianapolis, United StatesSee the site
- Trial code
- Registry title
- The Indiana Myeloma Registry
- Status
- Recruiting
- People taking part
- 2,500 people, planned
- Started
- 18 Jun 2018
- Expected to end
- 30 Jun 2028
- Type of study
- Observational
- Treatments tested
- This is a non-interventional trial
- Record updated
- 29 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have, or may have, MGUS, smoldering multiple myeloma, multiple myeloma, a plasmacytoma or primary amyloidosis. It collects data and samples for future research.
- Age
- 18 years or older
- Sex
- Men and women can join.
- Disease stage
- Diagnosed with or suspected to have one of these: MGUS, smoldering multiple myeloma, multiple myeloma, bony or soft tissue plasmacytoma, primary amyloidosis.
Main reasons for not taking part
- Younger than 18 years
- Not diagnosed with any of the listed conditions
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Male or female patients ≥ 18 years of age at the time of informed consent
- Has been diagnosed with or is suspected to have one of the following:; Monoclonal Gammopathy of Undetermined Significance (MGUS); Smoldering Multiple Myeloma; Multiple Myeloma; Bony or Soft Tissue Plasmacytoma; Primary Amyloidosis
Who cannot take part
- < 18 years of age
- Have not been diagnosed with one of the following:
- Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis
Where in United States
- Indiana University Simon Cancer CenterIndianapolis, United StatesContact: Attaya Suvannasankha, MDTaking people
About the trial
What the trial wants to find out
This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research
Treatments tested
- This is a non-interventional trial
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The Indiana Myeloma Registry
- Plain-language title
- Collects health data and samples from people with plasma cell disordersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 29 October 2026